Biocartis Group NV: BIOCARTIS ANNOUNCES SUCCESSFUL PLACEMENT OF EUR 150 MILLION SENIOR UNSECURED CONVERTIBLE BONDS DUE 9 MAY 2024

NEXT STORY
Blood Gas and Electrolyte Analyzers Market to Gain US$ 3.0 Billion by 2026 – TMR
PREV STORY
Generex Biotechnology Subsidiary NuGenerex Diagnostics Announces Sales for its Rapid Point-of-Care Malaria Diagnostic Test Kit
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

UPDATE — Reset Pharmaceuticals Enters into Exclusive Worldwide License Agreement with NYU Langone Health for Intellectual Property and Data on Psilocybin and Related Psychedelics for the Treatment of Mental Illness in Patients with Life-Threatening Diseases, Including Cancer

author_avatar
NASDAQ Market News

Back to Health Center Provides Summer Allergy Relief with Acupuncture

ALEXANDRIA, Va., June 05, 2016 (GLOBE NEWSWIRE) -- Many allergy sufferers turn to acupuncture ...

author_avatar
NASDAQ Market News

Vaxil Initiates Pre-Clinical Study in New Oncology Target

author_avatar
NASDAQ Market News